Octreotide Injection

Form: Injection

Strength: 50 mcg/mL, 100 mcg/mL, 200,cg/mL, 500 mcg/mL

Reference Brands: Sandostatin.(EU & US)

Category: Oncology Cancer Care

Octreotide Injection 50 mcg/mL, 100 mcg/mL, 200 mcg/mL, and 500 mcg/mL is used to manage symptoms and control the growth of neuroendocrine tumors in oncology. Primarily indicated for carcinoid tumors, GEP-NETs, and acromegaly, Octreotide works by mimicking the effects of somatostatin, regulating hormone production. It is available in subcutaneous or IV formulations and is a vital part of oncology B2B distribution in both the U.S. and EU, ensuring better symptom management and tumor control for patients suffering from neuroendocrine malignancies and related conditions.